Babaodan oral capsule
EHBHKY2017-01-016
Approved small_molecule active
Quick answer
Babaodan oral capsule for Hepatocellular Carcinoma is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hepatocellular Carcinoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active